Biomedtech News
Abivax to present at the 39th annual J.P. Morgan Healthcare Conference ahead of major clinical milestones
Discussion of Abivax Clinical Program involving Covid-19, Ulcerative Colitis, Crohn’s Disease and more
Abivax establishes clinical, regulatory and manufacturing framework for ABX464 phase 3 program and potential commercialization in 2021
Centers for Medicare & Medicaid Services (CMS) grant transitional pass-through (TPT) payment for Stryker's SpineJack® System
Great article about Abivax : what makes it a unique candidate to treat Covid-19
Abivax completes recruitment of ABX464 phase 2b induction study in ulcerative colitis
Abivax receives “Best Technology Award” at the European Mediscience Awards 2020
Abivax announces the success of its oversubscribed capital increase
Abivax secures € 15M non-dilutive financing from Kreos Capital
CARMAT is granted € 13M in national innovation funding to conduct the EFICAS study in France
